Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
BeyondSpring Pharmaceuticals, Inc
Scientific Title
Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion